Fig. 2. Proportion of ART-naïve and ART-experienced participants with HIV-1 drug resistance-associated mutations at >5% variant abundance.

Mutations were determined by HIV-1 whole-genome sequencing using the Stanford University HIV Drug Resistance Database (v9.4) to determine resistance-associated mutations. Data are shown by drug class. NRTI nucleoside reverse transcriptase inhibitor, NNRTI non-nucleoside reverse transcriptase inhibitor, INSTI integrase strand transfer inhibitor, PI protease inhibitor.